“INVESTIGATING NEURON-SPECIFIC ENOLASE AS A DIAGNOSTIC MARKER FOR EARLY DETECTION OF DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS”. 2024. Journal of Population Therapeutics and Clinical Pharmacology 31 (9): 1095-1105. https://doi.org/10.53555/jb11kw29.